Low incidence of COVID-19 in hidradenitis suppurativa: How to interpret it?

被引：5
|
作者：
Dewigne, Mathilde [1 ]
Orte Cano, Carmen [1 ]
Daoud, Mathieu [1 ,2 ]
del Marmol, Veronique [1 ,2 ]
Benhadou, Farida [1 ,2 ]
机构：
[1] Univ Libre Bruxelles, Hop Univ Erasme, Dermatol Dept, Brussels, Belgium
[2] European Hidradenitis Suppurat Fdn eV, Dessau, Germany
来源：
EXPERIMENTAL DERMATOLOGY | 2022年 / 31卷 / 03期
关键词：
D O I：
10.1111/exd.14475
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：435 / 436
页数：2
相关论文
共 50 条
  • [21] Updated findings from the global hidradenitis suppurativa COVID-19 registry
    Naik, Haley B.
    Alhusayen, Raed
    Guilbault, Sandra
    Ingram, John
    Lowes, Michelle A.
    Marzano, Angelo V.
    Villumsen, Bente
    Yannuzzi, Christine
    EXPERIMENTAL DERMATOLOGY, 2023, 32 : 55 - 55
  • [22] Evaluating the safety and efficacy of COVID-19 vaccination in patients with hidradenitis suppurativa
    Pakhchanian, Haig
    Raiker, Rahul
    DeYoung, Charles
    Yang, Sherry
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2022, 47 (06) : 1186 - 1188
  • [23] Exploring the risk of severe COVID-19 infection in patients with hidradenitis suppurativa
    Seltzer, Janyla A.
    Okeke, Chidubem A. V.
    Perry, Jessica D.
    Shipman, William D.
    Okoye, Ginette A.
    Byrd, Angel S.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (02) : E153 - E154
  • [24] Management of patients with hidradenitis suppurativa during COVID-19 vaccination: an experience from southern Italy. Comment on: 'Evaluating the safety and efficacy of COVID-19 vaccination in patients with hidradenitis suppurativa'
    Martora, Fabrizio
    Marasca, Claudio
    Battista, Teresa
    Fabbrocini, Gabriella
    Ruggiero, Angelo
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2022, 47 (11) : 2026 - 2028
  • [25] Adalimumab for treatment of hidradenitis suppurativa during the COVID-19 pandemic: Safety considerations
    Blaszczak, Alecia
    Trinidad, John C. L.
    Cartron, Alexander M.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (01) : E31 - E31
  • [26] Hidradenitis suppurativa: The importance of virtual outpatient care during COVID-19 pandemic
    Shah, Monica
    Naik, Haley B.
    Alhusayen, Raed
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (01) : E81 - E82
  • [27] Assessing the risk of adalimumab use for hidradenitis suppurativa during the COVID-19 pandemic
    Kearns, Donovan G.
    Chat, Vipawee S.
    Uppal, Shelley
    Wu, Jashin J.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : E433 - E434
  • [28] Telehealth use at a specialty hidradenitis suppurativa clinic during the COVID-19 pandemic
    Kim, Diana S.
    Kimball, Alexa B.
    Porter, Martina L.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB115 - AB115
  • [29] How to interpret and use COVID-19 serology and immunology tests
    Ong, David S. Y.
    Fragkou, Paraskevi C.
    Schweitzer, Valentijn A.
    Chemaly, Roy F.
    Moschopoulos, Charalampos D.
    Skevaki, Chrysanthi
    CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (07) : 981 - 986
  • [30] Impact of Treatment With TNF-α Inhibitors for Hidradenitis Suppurativa During the COVID-19 Pandemic
    Benesh, Gabrielle
    Andriano, Tyler M.
    Babbush, Kayla M.
    Hosgood, H. Dean
    Cohen, Steven R.
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2021, 25 (04) : 446 - 448
12345